98 related articles for article (PubMed ID: 10537368)
1. Correspondence re: P. Salven et al., leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor. Clin. Cancer Res., 5: 487-91, 1999.
Gunsilius E; Petzer AL; Gastl G
Clin Cancer Res; 1999 Oct; 5(10):2978-9. PubMed ID: 10537368
[No Abstract] [Full Text] [Related]
2. Correspondence re: M.L. George [correction of H.L. George] et al., Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging? Clin. Cancer Res., 6: 3147-3152, 2000.
Gunsilius E; Tschmelitsch J; Petzer AL
Clin Cancer Res; 2001 Feb; 7(2):443-4. PubMed ID: 11234902
[No Abstract] [Full Text] [Related]
3. Correspondence re: M. L. George et al., Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging? Clin. Cancer Res., 6: 3147-3152, 2000.
Salgado R; Vermeulen PB; Van Marck E; Benoy I; Dirix L
Clin Cancer Res; 2001 May; 7(5):1481-3. PubMed ID: 11350921
[No Abstract] [Full Text] [Related]
4. Correspondence re: K. Neben et al., high plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma. Clin. Cancer Res., 7: 2675-2681, 2001.
Go RS; Horstman AL
Clin Cancer Res; 2002 Aug; 8(8):2750; author reply 2751. PubMed ID: 12171909
[No Abstract] [Full Text] [Related]
5. Platelets and VEGF blood levels in cancer patients.
Gunsilius E; Gastl G
Br J Cancer; 1999 Sep; 81(1):185-6. PubMed ID: 10487633
[No Abstract] [Full Text] [Related]
6. Blood platelets and serum VEGF in cancer patients.
Vermeulen PB; Salven P; Benoy I; Gasparini G; Dirix LY
Br J Cancer; 1999 Jan; 79(2):370-3. PubMed ID: 9888483
[No Abstract] [Full Text] [Related]
7. Determination of vascular endothelial growth factor (VEGF) in circulating blood: significance of VEGF in various leucocytes and platelets.
Werther K; Christensen IJ; Nielsen HJ
Scand J Clin Lab Invest; 2002; 62(5):343-50. PubMed ID: 12387579
[TBL] [Abstract][Full Text] [Related]
8. Clinical usefulness of serum and plasma vascular endothelial growth factor in cancer patients: which is the optimal specimen?
Lee JK; Hong YJ; Han CJ; Hwang DY; Hong SI
Int J Oncol; 2000 Jul; 17(1):149-52. PubMed ID: 10853032
[TBL] [Abstract][Full Text] [Related]
9. Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma.
Poon RT; Lau CP; Cheung ST; Yu WC; Fan ST
Cancer Res; 2003 Jun; 63(12):3121-6. PubMed ID: 12810638
[TBL] [Abstract][Full Text] [Related]
10. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging?
George ML; Eccles SA; Tutton MG; Abulafi AM; Swift RI
Clin Cancer Res; 2000 Aug; 6(8):3147-52. PubMed ID: 10955796
[TBL] [Abstract][Full Text] [Related]
11. Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?
Tabone MD; Landman-Parker J; Arcil B; Coudert MC; Gerota I; Benbunan M; Leverger G; Dosquet C
Clin Cancer Res; 2001 Mar; 7(3):538-43. PubMed ID: 11297245
[TBL] [Abstract][Full Text] [Related]
12. Serum vascular endothelial growth factor load and interleukin-6 in cancer patients.
O'Byrne KJ; Dobbs N; Harris AL
Br J Cancer; 2000 Jun; 82(11):1895-6. PubMed ID: 10839310
[No Abstract] [Full Text] [Related]
13. Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. The Danish RANX05 Colorectal Cancer Study Group.
Werther K; Christensen IJ; Brünner N; Nielsen HJ
Eur J Surg Oncol; 2000 Nov; 26(7):657-62. PubMed ID: 11078612
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of postoperative serum vascular endothelial growth factor (VEGF)--can it be used to predict curative resections in colorectal cancer?
Kumar H; Heer K; Duthie GS; Monson JR
Anticancer Res; 2002; 22(6B):3717-22. PubMed ID: 12552982
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen.
Adams J; Carder PJ; Downey S; Forbes MA; MacLennan K; Allgar V; Kaufman S; Hallam S; Bicknell R; Walker JJ; Cairnduff F; Selby PJ; Perren TJ; Lansdown M; Banks RE
Cancer Res; 2000 Jun; 60(11):2898-905. PubMed ID: 10850435
[TBL] [Abstract][Full Text] [Related]
16. Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1.
Lissoni P; Malugani F; Bonfanti A; Bucovec R; Secondino S; Brivio F; Ferrari-Bravo A; Ferrante R; Vigoré L; Rovelli F; Mandalà M; Viviani S; Fumagalli L; Gardani GS
J Biol Regul Homeost Agents; 2001; 15(2):140-4. PubMed ID: 11501971
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of vascular endothelial growth factor (VEGF) and its receptor, Flt-1, in haematological cancers: a comparison with breast cancer.
Belgore FM; Lip GY; Bareford D; Wadley M; Stonelake P; Blann AD
Am J Hematol; 2001 Jan; 66(1):59-61. PubMed ID: 11426496
[TBL] [Abstract][Full Text] [Related]
18. Relationship between plasma levels of vascular endothelial growth factor and serum levels of interleukin-12 in patients with colorectal cancer.
Nakayama Y; Sako T; Shibao K; Onitsuka K; Nagashima N; Hirata K; Nagata N; Itoh H
Anticancer Res; 2000; 20(6A):4097-102. PubMed ID: 11131678
[TBL] [Abstract][Full Text] [Related]
19. Effect of multimodality therapy on circulating vascular endothelial growth factor levels in patients with oesophageal cancer.
McDonnell CO; Harmey JH; Bouchier-Hayes DJ; Walsh TN
Br J Surg; 2001 Aug; 88(8):1105-9. PubMed ID: 11488797
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of plasma vascular endothelial growth factor in patients with colorectal cancer.
Nakayama Y; Sako T; Shibao K; Okazaki K; Rempo N; Onitsuka K; Minagawa N; Akahane K; Nagashima N; Nagata N; Itoh H
Anticancer Res; 2002; 22(4):2437-42. PubMed ID: 12174940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
